Skip to main content
. 2021 Oct 7;5(Suppl 2):e12589. doi: 10.1002/rth2.12589
Index date: date of histological diagnosis of OS or ES

Osteosarcoma

VTE

% (95% CI)

Ewing sarcoma

VTE

% (95% CI)

Osteosarcoma

MB

% (95% CI)

Ewing sarcoma

MB

% (95% CI)

3 months 5.2 (3.5–7.3) 1.8 (0.50–4.8) 1.2 (0.48–2.4) 0
6 months 6.7 (4.8–9.1) 1.8 (0.50–4.8) 2.3 (1.3–3.9) 0.61 (0.06–3.1)
9 months 7.5 (5.4–10) 4.2 (1.9–8.1) 2.5 (1.4–4.1) 0.61 (0.06–3.1)
12 months 8.3 (6.1–11) 6.1 (3.1–10) 3.3 (2.0–5.1) 1.2 (0.24–4.0)
24 months 8.8 (6.6–11) 6.7 (3.5–11) 4.0 (2.6–6.0) 2.5 (0.81–5.8)

OS: osteosarcoma; ES: Ewing sarcoma; VTE: venous thromboembolism; MB: major bleeding; CI: confidence interval

Adjusted cumulative incidence: cumulative incidence adjusted for competing risk of death (following the CICR method).